[ad_1] BERLIN, Jan 4 (Reuters) – Germany was weighing on Monday whether to allow a delay in administering a second dose of the COVID-19 vaccine from BioNTech (22UAy.DE) and Pfizer…
Tag: BIODRG
Analysis: Weight loss drug candidates multiply, spurring hopes of better outcomes, lower costs
[ad_1] SAN DIEGO, June 27 (Reuters) – New data on weight loss drugs that could compete with Novo Nordisk’s Wegovy are raising expectations there will soon be more options, and…
France opts for mRNA vaccines for second coronavirus shot
[ad_1] [1/2] A vial of the Oxford-AstraZeneca COVID-19 vaccine is pictured at the Foch hospital in Suresnes, near Paris, France, February 8, 2021. REUTERS/Benoit Tessier/File Photo PARIS, April 9 (Reuters)…
BioNTech sees scope for further capacity expansion -CFO
[ad_1] BERLIN, April 21 (Reuters) – German COVID-19 vaccine maker BioNtech (22UAy.DE) is open to further capacity expansion and the construction of new production facilities depending on demand, Chief Financial…
Switzerland says Moderna COVID-19 vaccine deliveries will be delayed
[ad_1] [1/5] Medical praxis assistant Tosca Tiralosi injects the first dose of the Moderna Covid-19 vaccine to man at the Hausaerzte Hegibachplatz doctors office, as the spread of the coronavirus…
BioNTech faces first German lawsuit over alleged COVID vaccine side effects
[ad_1] HAMBURG, June 11 (Reuters) – BioNTech (22UAy.DE) will go to court on Monday to defend itself against a lawsuit from a German woman who is seeking damages for alleged…
Take Five: Who’s afraid of U.S. inflation?
[ad_1] [1/2] Photo d’archives des employés dans une usine du fabricant de composants SMC en Chine. /Photo prise le 13 mai 2020 à Pékin, Chine/REUTERS/Thomas Peter LONDON, April 9 (Reuters)…
Romania to sell excess COVID-19 vaccines to Denmark
[ad_1] COPENHAGEN, June 29 (Reuters) – Romania has agreed to sell 1.17 million doses of excess Pfizer/BioNTech (PFE.N), vaccines to Denmark, the Danish health ministry said on Tuesday. “We can…
US FDA halts enrollment in Mersana’s cancer drug studies, shares drop
[ad_1] June 15 (Reuters) – Mersana Therapeutics (MRSN.O) said on Thursday the U.S. Food and Drug Administration (FDA) had paused enrollment in two studies of its ovarian cancer drug after…
U.S. FTC focuses on deal with Japanese company in Shkreli trial
[ad_1] NEW YORK, Dec 14 (Reuters) – The U.S. Federal Trade Commission on Tuesday kicked off the trial of its civil case against Vyera Pharmaceuticals founder Martin Shkreli, grilling company…